Attana

Attana

Biosensors for the pharma, diagnostic and academic societies.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues<1m<1m<1m<1m<1m1.4m<1m
% growth(18 %)25 %60 %(13 %)14 %63 %(48 %)
EBITDA(<1m)(<1m)(<1m)(<1m)(1.8m)(1.4m)(1.3m)
% EBITDA margin(125 %)(100 %)(75 %)(129 %)(200 %)(100 %)(170 %)
Profit(<1m)(<1m)(<1m)(1.2m)(1.9m)(1.7m)(1.5m)
% profit margin(175 %)(120 %)(88 %)(157 %)(213 %)(115 %)(202 %)
EV / revenue-10.3x17.8x42.9x18.5x3.5x4.4x
EV / EBITDA--10.3x-23.8x-33.4x-9.3x-3.5x-2.6x
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

SEK6.4m

Early VC

€280k

Grant
N/A

N/A

IPO
Total FundingAUD1.7m

Recent News about Attana

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.